164 related articles for article (PubMed ID: 35788036)
41. ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition.
Anderson MG; Zhang Q; Rodriguez LE; Hecquet CM; Donawho CK; Ansell PJ; Reilly EB
BMC Cancer; 2021 Jun; 21(1):681. PubMed ID: 34107902
[TBL] [Abstract][Full Text] [Related]
42. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion.
Dimasi N; Fleming R; Zhong H; Bezabeh B; Kinneer K; Christie RJ; Fazenbaker C; Wu H; Gao C
Mol Pharm; 2017 May; 14(5):1501-1516. PubMed ID: 28245132
[TBL] [Abstract][Full Text] [Related]
43. Development of a Novel DNA Mono-alkylator Platform for Antibody-Drug Conjugates.
Thomas JD; Yurkovetskiy AV; Yin M; Bodyak ND; Tang S; Protopopova M; Kelleher E; Jones B; Yang L; Custar D; Catcott KC; Demady DR; Collins SD; Xu L; Bu C; Qin L; Ter-Ovanesyan E; Damelin M; Toader D; Lowinger TB
Mol Cancer Ther; 2024 Apr; 23(4):541-551. PubMed ID: 38354416
[TBL] [Abstract][Full Text] [Related]
44. DNA sequence-selective C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates show anti-tubercular-specific activities.
Brucoli F; Guzman JD; Basher MA; Evangelopoulos D; McMahon E; Munshi T; McHugh TD; Fox KR; Bhakta S
J Antibiot (Tokyo); 2016 Dec; 69(12):843-849. PubMed ID: 27168314
[TBL] [Abstract][Full Text] [Related]
45. Design, synthesis and in vitro cytotoxic studies of novel bis-pyrrolo[2,1][1,4] benzodiazepine-pyrrole and imidazole polyamide conjugates.
Kumar R; Lown JW
Eur J Med Chem; 2005 Jul; 40(7):641-54. PubMed ID: 15935899
[TBL] [Abstract][Full Text] [Related]
46. Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer.
Abdollahpour-Alitappeh M; Lotfinia M; Bagheri N; Sineh Sepehr K; Habibi-Anbouhi M; Kobarfard F; Balalaie S; Foroumadi A; Abbaszadeh-Goudarzi G; Abbaszadeh-Goudarzi K; Abolhassani M
J Cell Physiol; 2019 Mar; 234(3):2693-2704. PubMed ID: 30246298
[TBL] [Abstract][Full Text] [Related]
47. Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopes.
Feng Y; Wang Y; Zhu Z; Li W; Sussman RT; Randall M; Bosse KR; Maris JM; Dimitrov DS
MAbs; 2016; 8(4):799-810. PubMed ID: 26910291
[TBL] [Abstract][Full Text] [Related]
48. Optimization of a PEGylated Glucuronide-Monomethylauristatin E Linker for Antibody-Drug Conjugates.
Burke PJ; Hamilton JZ; Jeffrey SC; Hunter JH; Doronina SO; Okeley NM; Miyamoto JB; Anderson ME; Stone IJ; Ulrich ML; Simmons JK; McKinney EE; Senter PD; Lyon RP
Mol Cancer Ther; 2017 Jan; 16(1):116-123. PubMed ID: 28062707
[TBL] [Abstract][Full Text] [Related]
49. Design and Characterization of Immune-Stimulating Imidazo[4,5-c]quinoline Antibody-Drug Conjugates.
Fang S; Brems BM; Olawode EO; Miller JT; Brooks TA; Tumey LN
Mol Pharm; 2022 Sep; 19(9):3228-3241. PubMed ID: 35904247
[TBL] [Abstract][Full Text] [Related]
50. A New Triglycyl Peptide Linker for Antibody-Drug Conjugates (ADCs) with Improved Targeted Killing of Cancer Cells.
Singh R; Setiady YY; Ponte J; Kovtun YV; Lai KC; Hong EE; Fishkin N; Dong L; Jones GE; Coccia JA; Lanieri L; Veale K; Costoplus JA; Skaletskaya A; Gabriel R; Salomon P; Wu R; Qiu Q; Erickson HK; Lambert JM; Chari RV; Widdison WC
Mol Cancer Ther; 2016 Jun; 15(6):1311-20. PubMed ID: 27197308
[TBL] [Abstract][Full Text] [Related]
51. A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity.
Yao X; Jiang J; Wang X; Huang C; Li D; Xie K; Xu Q; Li H; Li Z; Lou L; Fang J
Breast Cancer Res Treat; 2015 Aug; 153(1):123-33. PubMed ID: 26253944
[TBL] [Abstract][Full Text] [Related]
52. Evaluating
Lakes AL; An DD; Gauny SS; Ansoborlo C; Liang BH; Rees JA; McKnight KD; Karsunky H; Abergel RJ
Mol Pharm; 2020 Nov; 17(11):4270-4279. PubMed ID: 33044830
[TBL] [Abstract][Full Text] [Related]
53. An FDA oncology analysis of toxicities associated with PBD-containing antibody-drug conjugates.
Saber H; Simpson N; Ricks TK; Leighton JK
Regul Toxicol Pharmacol; 2019 Oct; 107():104429. PubMed ID: 31325532
[TBL] [Abstract][Full Text] [Related]
54. Design, synthesis and in vitro cytotoxicity studies of novel pyrrolo [2,1][1,4] benzodiazepine-glycosylated pyrrole and imidazole polyamide conjugates.
Kumar R; Lown JW
Org Biomol Chem; 2003 Oct; 1(19):3327-42. PubMed ID: 14584797
[TBL] [Abstract][Full Text] [Related]
55. Novel PIKK inhibitor antibody-drug conjugates: Synthesis and anti-tumor activity.
Zhou D; Casavant J; Graziani EI; He H; Janso J; Loganzo F; Musto S; Tumey N; O'Donnell CJ; Dushin R
Bioorg Med Chem Lett; 2019 Apr; 29(7):943-947. PubMed ID: 30655215
[TBL] [Abstract][Full Text] [Related]
56. Therapeutic potential of SGN-CD19B, a PBD-based anti-CD19 drug conjugate, for treatment of B-cell malignancies.
Ryan MC; Palanca-Wessels MC; Schimpf B; Gordon KA; Kostner H; Meyer B; Yu C; Van Epps HA; Benjamin D
Blood; 2017 Nov; 130(18):2018-2026. PubMed ID: 28903943
[TBL] [Abstract][Full Text] [Related]
57. Antibody-Drug Conjugate Efficacy in Neuroblastoma: Role of Payload, Resistance Mechanisms, Target Density, and Antibody Internalization.
Buongervino S; Lane MV; Garrigan E; Zhelev DV; Dimitrov DS; Bosse KR
Mol Cancer Ther; 2021 Nov; 20(11):2228-2239. PubMed ID: 34465595
[TBL] [Abstract][Full Text] [Related]
58. Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life Extension.
Li Q; Barrett A; Vijayakrishnan B; Tiberghien A; Beard R; Rickert KW; Allen KL; Christie RJ; Marelli M; Harper J; Howard P; Wu H; Dall'Acqua WF; Tsui P; Gao C; Borrok MJ
Bioconjug Chem; 2019 Apr; 30(4):1232-1243. PubMed ID: 30912649
[TBL] [Abstract][Full Text] [Related]
59. A Novel NAMPT Inhibitor-Based Antibody-Drug Conjugate Payload Class for Cancer Therapy.
Böhnke N; Berger M; Griebenow N; Rottmann A; Erkelenz M; Hammer S; Berndt S; Günther J; Wengner AM; Stelte-Ludwig B; Mahlert C; Greven S; Dietz L; Jörißen H; Barak N; Bömer U; Hillig RC; Eberspaecher U; Weiske J; Giese A; Mumberg D; Nising CF; Weinmann H; Sommer A
Bioconjug Chem; 2022 Jun; 33(6):1210-1221. PubMed ID: 35658441
[TBL] [Abstract][Full Text] [Related]
60. Synthesis of a heterotrifunctional linker for the site-specific preparation of antibody-drug conjugates with two distinct warheads.
Kumar A; Kinneer K; Masterson L; Ezeadi E; Howard P; Wu H; Gao C; Dimasi N
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3617-3621. PubMed ID: 30389292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
